OKYO Pharma Limited - Ordinary Shares - New
OKYO Pharma Limited - Ordinary Shares - New Stock, NASDAQ:OKYO
OKYO Pharma Ltd operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It operates through the US and UK geographical segments. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.